LRRC1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.850500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.957800E-01
Normal-vs-Stage2
4.395500E-02
Normal-vs-Stage3
6.700000E-01
Normal-vs-Stage4
1.103810E-01
Stage1-vs-Stage2
6.173600E-01
Stage1-vs-Stage3
2.625600E-01
Stage1-vs-Stage4
8.359800E-01
Stage2-vs-Stage3
6.386400E-02
Stage2-vs-Stage4
8.815000E-01
Stage3-vs-Stage4
1.557240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.497900E-02
Normal-vs-AfricanAmerican
9.817800E-02
Normal-vs-Asian
6.254200E-02
Caucasian-vs-AfricanAmerican
5.858400E-01
Caucasian-vs-Asian
4.630100E-02
AfricanAmerican-vs-Asian
5.321000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.926300E-02
Normal-vs-Female
8.134100E-02
Male-vs-Female
2.654800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.161000E-01
Normal-vs-Age(41-60Yrs)
4.759600E-02
Normal-vs-Age(61-80Yrs)
7.606100E-02
Normal-vs-Age(81-100Yrs)
4.427900E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.396800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.792400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.465800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.166370E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.868000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.642200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.393600E-02
Normal-vs-Daily Drinker
1.759610E-01
Normal-vs-Weekly Drinker
1.421980E-01
Normal-vs-Occasional Drinker
2.950100E-02
Normal-vs-Social Drinker
6.594300E-02
Non Drinker-vs-Daily Drinker
6.359800E-01
Non Drinker-vs-Weekly Drinker
9.720200E-01
Non Drinker-vs-Occasional Drinker
2.265400E-01
Non Drinker-vs-Social Drinker
6.821600E-01
Daily Drinker-vs-Weekly Drinker
6.977400E-01
Daily Drinker-vs-Occasional Drinker
1.477990E-01
Daily Drinker-vs-Social Drinker
9.527200E-01
Weekly Drinker-vs-Occasional Drinker
3.665400E-01
Weekly Drinker-vs-Social Drinker
7.201600E-01
Occasional Drinker-vs-Social Drinker
1.406840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.629700E-02
Normal-vs-Grade 2
1.009640E-02
Normal-vs-Grade 3
2.740100E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.800200E-04
Grade 1-vs-Grade 3
5.71759999999921E-05
Grade 1-vs-Grade 4
3.629700E-02
Grade 2-vs-Grade 3
3.268200E-01
Grade 2-vs-Grade 4
1.009640E-02
Grade 3-vs-Grade 4
2.740100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.391160E-01
Normal-vs-NonDiabetic
4.579600E-02
Diabetic-vs-NonDiabetic
6.718200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.442400E-02
Normal-vs-NoPancreatitis
6.954300E-02
Pancreatitis-vs-NoPancreatitis
7.583800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.859900E-02
Normal-vs-N1
4.869900E-02
N0-vs-N1
6.995800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.758300E-03
Normal-vs-TP53-NonMutant
8.502300E-02
TP53-Mutant-vs-TP53-NonMutant
2.225400E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
